Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB864)
Received: 24 January 2020
Accepted: 22 April 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. [<sup>99m</sup>Tc]Tc-PSMA-I&S-SPECT/CT imaging was performed on a compassionate use basis according to German Medicinal Products Act (AMG §13.2b) and the responsible regulatory bodies (Government of Oberbayern and Saxony, Germany).
: Consent for publication was obtained from all individual participants included in the study.
: Hans-Jürgen Wester is founder and shareholder of Scintomics GmbH. All other authors declare that they have no conflict of interest.